CD276 and cancer: In conclusion, B7-H3 may represent an interesting potential immunotherapeutic target for ampullary cancer of the pancreato-biliary subtype, because it is expressed in cancer cells of about half of the patients, and in about two-thirds of patients in tumoral stroma.